Articles citing this paper
Macrolide use and the risk of vascular disease in HIV-infected men in the Multicenter AIDS Cohort Study
Ian J. Woolley A E , Xiuhong Li B , Lisa P. Jacobson B , Frank J. Palella C and Lars Ostergaard D
+ Author Affiliations
- Author Affiliations
A Infectious Diseases Department, Alfred Hospital, Monash University Medical School, Prahran 3004, Victoria, Australia.
B Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205, USA.
C Northwestern University, Feinberg School of Medicine, Division of Infectious Diseases, Chicago, Illinois 60611, USA.
D Research Unit Q, Department of Infectious Diseases, Skejby Sygehus, Aarhus University Hospital, 8200 Aarhus N, Denmark.
E Corresponding author. Email: Ian.Woolley@med.monash.edu.au
Sexual Health 4(2) 111-119 https://doi.org/10.1071/SH06052
Submitted: 8 September 2006 Accepted: 26 March 2007 Published: 23 May 2007
2 articles found in Crossref database.
Managing Cardiovascular Risk of Macrolides: Systematic Review and Meta-Analysis
Wong Angel Y. S.,
Chan Esther W.,
Anand Shweta,
Worsley Alan J., Wong Ian C. K.
Drug Safety. 2017 40(8). p.663
Endothelial dysfunction, increased inflammation, and activated coagulation in HIV‐infected patients improve after initiation of highly active antiretroviral therapy
Arildsen H,
Sørensen KE,
Ingerslev JM,
Østergaard LJ, Laursen AL
HIV Medicine. 2013 14(1). p.1
